Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 85/100

Termination Rate

11.1%

1 terminated out of 9 trials

Success Rate

0.0%

-86.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

6Total
Not Applicable (5)
P 2 (1)

Trial Status

Recruiting6
Not Yet Recruiting2
Terminated1

Clinical Trials (9)

Showing 9 of 9 trials
NCT07572903Not ApplicableNot Yet RecruitingPrimary

The Efficacy and Safety of Temporal Interference Stimulation on Motor Symptoms of Parkinson's Disease

NCT07554833Not ApplicableNot Yet Recruiting

Effects of Accelerated rTMS On Motor and Cognitive Function in Parkinson's Disease

NCT07217054Recruiting

Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder

NCT07378722Not ApplicableRecruitingPrimary

Rhythmic Auditory Stimulaton Using Personalized Music Therapy in Parkinson's Disease

NCT07359716Not ApplicableRecruitingPrimary

Virtual Reality Verses Conventional Physical Therapy in Parkinson's Disease Patients

NCT07284719Not ApplicableRecruitingPrimary

MRgFUS for Parkinson's Tremor

NCT07312110Phase 2RecruitingPrimary

D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression

NCT07148700Recruiting

Which Tools Better Predict Fall Risk in Parkinson's Disease: A Comparative Study of Objective, Self-Reported, and Functional Balance Assessment

NCT01105845TerminatedPrimary

Genetics of Motor Learning

Showing all 9 trials

Research Network

Activity Timeline